Artificial intelligence prognostication of liver disease using imaging.
Manil D Chouhan1,2, Kate McLean1,2, James A Thomas2,3
1Department of Diagnostic Radiology, Princess Alexandra Hospital, Woolloongabba, Queensland, 4102, Australia.
The British Journal of Radiology
|March 31, 2026
Summary
Artificial intelligence (AI) enhances prognostic models for chronic liver disease (CLD) using medical imaging like ultrasound, CT, and MRI. AI improves predictions of liver-related outcomes, aiding clinical decisions and reducing healthcare costs.
Area of Science:
- Radiology
- Medical Informatics
- Hepatology
Background:
- Accurate prognostication in chronic liver disease (CLD) is crucial for patient management and cost reduction.
- Artificial intelligence (AI) offers potential for improving prognostic models through advanced image analysis.
- Current prognostic tools for CLD require enhancement for better clinical utility.
Purpose of the Study:
- To review the application of AI in prognostic models for CLD using various imaging modalities.
- To assess the strengths, weaknesses, and clinical translation challenges of AI-driven prognostic tools in CLD.
- To identify future research directions for AI in CLD prognostication.
Main Methods:
- Narrative review of AI applications in prognostic models for CLD.
- Analysis of AI integration with ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI).
- Examination of AI-based models using a prognostic endpoint-based approach.
Main Results:
- AI algorithms show promise in segmentation, detection, and classification tasks for CLD imaging.
- AI can extract imaging features or build predictive models directly for prognostication.
- Limitations in AI application and data hinder widespread clinical translation.
Conclusions:
- AI holds significant potential to improve prognostic accuracy and clinical outcomes in CLD patients.
- Addressing current limitations is key for the successful clinical implementation of AI in CLD prognostication.
- Further research is needed to overcome challenges and optimize AI-based prognostic tools for CLD.


